Thursday, June 19 is Juneteenth. Our lab will be open and accepting samples, but our genetic counseling services, client services, and billing services teams will be unavailable. If you need assistance, please leave a message at 888-729-1206 or Support@GeneDx.com and we will respond when we return on June 20.

CLARITY STARTS HERE

Genomic Sequencing:
Begin with a comprehensive approach

From first signs to clear answers—our genomic sequencing solutions help you connect the clinical dots, faster.

Compare products

What’s the cost of waiting?

The average journey to a genetic diagnosis is five or more years.¹ That’s far too long.

And it can cost up to $10,000 before a diagnosis is reached.² That’s far too much.

From data to diagnosis—with confidence.

Answers in days, not years.

One of the largest and most diverse databases

Our database includes 1.5M+ unique samples—including 800K sequenced exomes and genomes. Nearly 50% represent individuals of non-European ancestry. This diversity strengthens rare variant interpretation.

Higher diagnostic yield, clearer reports

Exome and genome sequencing analyze over 20,000 genes to find answers that other tests miss. Our tests lead to more diagnoses—delivered in reports that are concise, clear, and easy to act on.

Genetic counseling support for your patients

A genetic diagnosis can be overwhelming. Our team of experts support both you and your patients—from understanding results to connecting families with others on similar journeys.

Choose the right test for your patients

Exome Sequencing

Often the first, most effective step when a genetic cause is suspected. That’s because most known disease-causing variants are found within the exome.

Learn more

Genome Sequencing

The most complete view of the genome, offering deeper insights beyond the exome when a broader search is needed.

Learn more

Backed by guidelines

Exome and genome testing are recommended and endorsed as first-line tests for multiple indications.

See clinical guidelines

Broad clinical applications

Epilepsy

Autism spectrum disorder

Cerebral palsy

Developmental delays

Patients in the NICU

Getting started is simple. We’re with you at every step.

Order

tests through our Provider Portal

Submit

your patient’s sample

Track

your test in real time

Review

your patient’s results in an easy-to-read report

Check out our ordering page for more detailed information.

Less paperwork.
More patient care.

More patients are covered for exome and genome testing than you may think.

We’re in network with many commercial and government payors, making genomics accessible for more patients.

See if your patients are covered

Patient support & resources

From our Patient Access Solutions to our Epilepsy Partnership Program, we’re here to help families manage costs—no matter their insurance status.

Our Patient Access Solutions can help ease financial stress and offset out-of-pocket costs.

Our Epilepsy Partnership Program helps patients with epilepsy get the testing they need–even if their insurance doesn’t cover the cost, or if a claim gets denied.

What a genetic diagnosis meant for these families

From confusion to clarity—and a clear path forward. See the impact GeneDx testing made.

“The diagnosis gave me more peace of mind, less fear, less worry, less pressure on myself.”

—Ben’s mother

“Information gave us power. We were able to make changes immediately that were practical and had real implications for how we take care of Margot.”

—Lili, parent of a child with a CDKL5 gene variant

“The more information you have earlier, the more you’re potentially able to do and help your child’s long-term outcome.”

—Andrea

Bring clarity to more families

Explore how genomic testing can transform your practice.

Reach out to a representative

*Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.

References: 1. Marwaha S, Knowles JW, and Ashley EA. Genome Med. 2022 Feb 28;14(1):23. doi: 10.1186/s13073-022-01026-w. 2. Soden SE, Saunders CJ, Willig LK, et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med. 2014 Dec 3;6(265):265ra168. doi: 10.1126/scitranslmed.3010076. 3. Lunke S, Bouffler SE, Patel CV et al. Nat Med. 2023 Jun 8. 4. Maron JL, Kingsmore S, Gelb BD, et al. JAMA. 2023 Jul 11;330(2):161-169. 5. Dimmock D, Caylor S, Waldman B, et al. Am J Hum Genet. 2021 Jul 1;108(7):1231-1238. 6. Manickam K, McClain MR, Demmer LA et. al; ACMG Board of Directors. Genet Med. 2021 Nov;23(11):2029-2037. 7. Sheidley BR, Malinowski J, Bergner AL, et al. Epilepsia. 2022 Feb;63(2):375-387. 8. Lewis SA, Ruttenberg A, Iyiyol T, et al. EBioMedicine. 2024 Aug;106:105229. 9. Srivastava S, Love-Nichols JA, Dies KA, et al. Genet Med. 2019 Nov;21(11):2413–2421. 10. Chen E, Facio FM, Aradhya KW, R, et al. JAMA Netw Open. 2023 Oct 2;6(10):e2339571. 11. Savatt JM, Myers SM. Front Pediatr. 2021 Feb 19;9:526779. 12. Srivastava S, Love-Nichols JA, Dies KA, et al. Genet Med. 2019 Nov;21(11):2413–2421.

Genomic Sequencing: Begin with a comprehensive approach